跳至主要内容
临床试验/IRCT2016031425726N4
IRCT2016031425726N4已完成未知

Effects of high dose vitamin D? ?as adjunctive therapy on ?clinical outcomes and prognostic biomarkers in patients with Acute ?Exacerbation of Chronic Obstructive ?? ?Pulmonary Disease. ?

Research council of School of Pharmacy, Shahid Beheshti University0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 139 years(—)
性别
All

入选标准

  • Inclusion criteria include;
  • Vitamin D deficiency (serum 25(OH)D < 50 nmol/l) ?
  • Postbronchodilator FEV1/FVC < 0.70, FEV1< 80 % and
  • diagnosis acute exacerbation of COPD confirmed by a physician
  • Age=40 years ?
  • Written informed consent ?
  • Ability to comply with all study requirements
  • Exclusion criteria include
  • Severe vitamin D deficiency (serum 25(OH)D <15 nmol/l),?
  • Use of a supplement containing more than 400 IU vitamin D per day
  • Diagnosed asthma
  • Diagnosed osteoporosis
  • Self-reported history of hypercalcaemia or nephrolithiasis
  • Self-reported presence of sarcoidosis
  • Diagnosed chronic kidney disease stage 4 or higher (eGFR=29 ml/min/1.73 m2)?
  • liver insufficiency child pough class B or C
  • Interfering malignant diseases
  • Life expectation of less than 1 year on the basis of concurrent disease
  • Current participation in a clinical rehabilitation program
  • Pregnant or lactating women, or subjects who intend to become
  • pregnant within the study period
  • Potentially unreliable patients and those judged by the investigator
  • to be unsuitable for the study
  • Serious mental impairment i.e. preventing to understand the study
  • protocol or comply with the study aim.

排除标准

  • 未提供

研究者

发起方
Research council of School of Pharmacy, Shahid Beheshti University

相似试验